Sign In
Buy RVTY
$101.07
+0.680 (+0.677%)
At Close: Jun 03, 2026
Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook
01:40pm, Monday, 28'th Jul 2025
Revvity (RVTY) was one of the worst-performing stocks in the S&P 500 Monday after the medical device maker said it anticipated a "meaningful pullback" in its immunodiagnostics business in China.
Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More
12:25pm, Monday, 28'th Jul 2025
U.S. equities were mhigher at midday after President Donald Trump and European Commission President Ursula von der Leyen announced a new trade agreement between the U.S. and the European Union. The
Revvity, Inc. (RVTY) Q2 2025 Earnings Call Transcript
11:59am, Monday, 28'th Jul 2025
Revvity, Inc. (NYSE:RVTY ) Q2 2025 Earnings Conference Call July 28, 2025 8:00 AM ET Company Participants Maxwell Krakowiak - Senior VP & CFO Prahlad R. Singh - CEO, President & Director Stephen Barr
RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View
11:16am, Monday, 28'th Jul 2025
Revvity's second-quarter results showcase strong growth in its Diagnostics business, along with recovery in Life Sciences segmental sales.
Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Monday, 28'th Jul 2025
Although the revenue and EPS for Revvity (RVTY) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street e
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
08:13am, Monday, 28'th Jul 2025
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.3% on Monday.
Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates
08:10am, Monday, 28'th Jul 2025
Revvity (RVTY) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.22 per share a year ago.
Revvity trims 2025 profit forecast on soft demand for diagnostics in China
08:09am, Monday, 28'th Jul 2025
Medical equipment maker Revvity on Monday lowered its full-year adjusted profit forecast as it expects demand for its diagnostics products in some international markets to remain soft, sending the com
Revvity Stock Tumbles After Earnings. What's Dragging on the Shares.
07:39am, Monday, 28'th Jul 2025
The health sciences company posts better-than-expected adjusted earnings and revenue but trims its guidance.
Revvity Q2 Revenue Up 4 Percent
07:34am, Monday, 28'th Jul 2025
Revvity Q2 Revenue Up 4 Percent
Revvity Announces Financial Results for the Second Quarter of 2025
06:00am, Monday, 28'th Jul 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the second quarter ended June 29, 2025. The Company reported GAAP earnings per share of $0.46, as comp
Why Revvity (RVTY) is Poised to Beat Earnings Estimates Again
01:10pm, Friday, 25'th Jul 2025
Revvity (RVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Revvity Board Declares Quarterly Dividend
04:05pm, Thursday, 24'th Jul 2025
WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on November 7,
Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat?
12:16pm, Thursday, 24'th Jul 2025
RVTY is likely to see another earnings beat as Diagnostics momentum and Signals Software growth offset tariff headwinds.
Wall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 Earnings
10:16am, Wednesday, 23'rd Jul 2025
Beyond analysts' top-and-bottom-line estimates for Revvity (RVTY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
